Chemically-enhanced primer compositions, methods and kits

Patent metadata

Field	Value
Publication number	US-9708650-B2
Application number	US-201414198308-A
Country	US
Kind code	B2
Filing date	Mar 5, 2014
Priority date	Oct 28, 2010
Publication date	Jul 18, 2017
Grant date	Jul 18, 2017

Abstract

A chemically-enhanced primer is provided comprising a negatively charged moiety (NCM), an oligonucleotide sequence having a) non-nuclease resistant inter-nucleotide linkages or b) at least one nuclease resistance inter-nucleotide linkage. The chemically-enhanced primer can be used for sequencing and fragment analysis. Methods for synthesizing the chemically-enhanced primer as well as a method of preparing DNA for sequencing, a method of sequencing DNA, and kits containing the chemically-enhanced primer are also provided. The method of sequencing DNA can comprise contacting amplification reaction products with the composition wherein excess amplification primer is degraded by the nuclease and the chemically-enhanced primer is essentially non-degraded.

First claim

We claim:

1. A method for sequencing DNA, comprising the steps of:
a. amplifying DNA in a first reaction mixture comprising nuclease-sensitive amplification primers to form amplified DNA;
b. contacting the first reaction mixture of the amplifying step with a second reaction mixture comprising a nuclease and a chemically-enhanced primer, the chemically-enhanced primer comprises an oligonucleotide sequence having a nuclease resistance inter-nucleotide linkage and a negatively charged moiety (NCM), and the NCM comprises a moiety having a structure of the following formula:

wherein each n is independently an integer of 1 to 9, and x is an integer of 2 to about 30;
c. inactivating the nuclease; and
d. reacting the amplified DNA in a sequencing reaction wherein the chemically-enhanced primer primes the sequencing reaction.

2. The method of claim 1 , further comprising:
obtaining sequencing results based on the sequencing reaction; and
determining a nucleotide base sequence of the amplified DNA based on the results.

3. The method of claim 1 , wherein amplifying DNA comprises the step of polymerase chain reaction amplification.

4. The method of claim 1 , wherein the nuclease is selected from exonuclease I, Exo III, Pfu and DNA pol I.

5. The method of claim 1 , wherein the chemically-enhanced primer has structure of Formula I:

wherein B is a nucleobase;
K is S or O;
each instance of n is independently an integer of 1 to 9;
m is 0 or 1;
x is an integer of 2 to about 30;
z is an integer of 3 to about 100;
W is OH, F, OMe, or H; and
Nt is a moiety having a formula:

6. The method of claim 1 , wherein the chemically-enhanced primer has a structure of the formula:
(Cn) x -OLIGO, wherein (Cn) x has a structure of the following formula:

wherein each instance of n is independently an integer of 1 to 9; and x is an integer of 2 to about 30;
OLIGO has a structure of the following formula:

wherein B is a nucleobase;
K is S or O;
m is 0 or 1;
z is an integer of 3 to about 100;
W is OH, F, OMe, or H; and
Nt is a moiety having a formula:

7. The method of claim 1 , wherein the chemically-enhanced primer comprises one nuclease-resistant linkage at a terminal 3′ end.

8. The method of claim 1 , wherein the sequencing reaction comprises cycle sequencing.

9. The method of claim 1 , wherein the chemically-enhanced primer comprises a plurality of NCMs either at a terminal 5′ end or within an oligonucleotide sequence of the chemically-enhanced primer.

Assignees

• Life Technologies Corp

Inventors

• Lee Linda
• Woo Sam
• Ma Peter

Classifications

• C12Q1/6874 Primary

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

• C12Q1/686 Primary

  Polymerase chain reaction [PCR] · CPC title

• C12Q1/6869 Primary

  Methods for sequencing · CPC title

• C12Q2525/125

  incorporating agents resulting in resistance to degradation · CPC title

• C12Q2525/113

  incorporating modified backbone · CPC title